Approximately 20% of workers in industrialized nations work nonstandard schedules such as rotating and night shifts. Shift workers frequently report sleep disturbances, fatigue while working, and impaired performance. As a result, many workers take medications in order to counterbalance abrupt shift change-related negative effects. Recently, we developed a naturalistic laboratory model of shift work and have begun characterizing drug effects on individuals working irregular schedules. In the proposed studies, we will expand our evaluations of drug interactions with workplace contingencies by evaluating the effects of modafinil and marijuana on workplace-relevant behaviors during day shift and night shift work. The results from these studies may be of particular significance in occupations that require abrupt changes in work schedules, e.g., health care workers, police officers, and military personnel. Further, using our carefully-controlled, residential laboratory procedures, we will begin a systematic evaluation of the effects of more recent relevant abused """"""""club drugs"""""""" MDMA and GHB on workplace performance. Our studies on club drugs will also evaluate the effects of methamphetamine alone, and the effects of drug combinations. In these studies, the effects of acute and repeated club drug administration on performance the day of administration, as well as on performance the morning after administration, i.e., """"""""hangover,"""""""" on a variety of behaviors relevant to workplace performance will be determined. Despite the fact that club drugs are frequently used by the working public, there is a limited database evaluating their effects on workplace-relevant behaviors. The results from these studies will provide for the first time a scientific database about the workplace-related consequences of acute and repeated dosing of several popular club drugs. Together, the data from the proposed studies will have substantial public health impact and will serve both educational and public policy functions.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
2R01DA003476-19A2
Application #
6872657
Study Section
Biobehavioral Regulation, Learning and Ethology Study Section (BRLE)
Program Officer
Schnur, Paul
Project Start
1983-08-01
Project End
2009-07-31
Budget Start
2004-09-30
Budget End
2005-07-31
Support Year
19
Fiscal Year
2004
Total Cost
$483,954
Indirect Cost
Name
New York State Psychiatric Institute
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Keith, Diana R; Gunderson, Erik W; Haney, Margaret et al. (2017) Smoked marijuana attenuates performance and mood disruptions during simulated night shift work. Drug Alcohol Depend 178:534-543
Dakwar, Elias; Levin, Frances; Foltin, Richard W et al. (2014) The effects of subanesthetic ketamine infusions on motivation to quit and cue-induced craving in cocaine-dependent research volunteers. Biol Psychiatry 76:40-6
Kirkpatrick, Matthew G; Gunderson, Erik W; Levin, Frances R et al. (2012) Acute and residual interactive effects of repeated administrations of oral methamphetamine and alcohol in humans. Psychopharmacology (Berl) 219:191-204
Hart, Carl L; Ilan, Aaron B; Gevins, Alan et al. (2010) Neurophysiological and cognitive effects of smoked marijuana in frequent users. Pharmacol Biochem Behav 96:333-41
Kirkpatrick, Matthew G; Haney, Margaret; Vosburg, Suzanne K et al. (2010) Zolpidem does not serve as reinforcer in humans subjected to simulated shift work. Drug Alcohol Depend 112:168-71
Haney, Margaret; Bisaga, Adam; Foltin, Richard W (2003) Interaction between naltrexone and oral THC in heavy marijuana smokers. Psychopharmacology (Berl) 166:77-85
Haney, M; Ward, A S; Comer, S D et al. (2001) Bupropion SR worsens mood during marijuana withdrawal in humans. Psychopharmacology (Berl) 155:171-9
Haney, M; Ward, A S; Comer, S D et al. (1999) Abstinence symptoms following oral THC administration to humans. Psychopharmacology (Berl) 141:385-94
Evans, S M; Foltin, R W; Fischman, M W (1999) Food ""cravings"" and the acute effects of alprazolam on food intake in women with premenstrual dysphoric disorder. Appetite 32:331-49
Haney, M; Ward, A S; Comer, S D et al. (1999) Abstinence symptoms following smoked marijuana in humans. Psychopharmacology (Berl) 141:395-404

Showing the most recent 10 out of 46 publications